Instem plc Issue of Equity & Total Voting Rights (2685S)
September 29 2017 - 7:17AM
UK Regulatory
TIDMINS
RNS Number : 2685S
Instem plc
29 September 2017
Instem plc
("Instem" or the "Company")
Issue of Equity and Total Voting Rights
Instem plc (AIM: INS), a leading provider of IT solutions and
services to the global life sciences market, announces that,
following the exercise of vested EMI share options, 20,000 ordinary
shares of 10p each in the Company ("Ordinary Shares") have been
issued.
Application has been made to the London Stock Exchange for the
admission of the 20,000 new Ordinary Shares to trading on AIM.
Admission is expected to take place at 8.00am on 4 October
2017.
Total Voting Rights
Following the issue and allotment of the above New Ordinary
Shares, the Company's issued share capital will comprise of
15,886,660 Ordinary Shares. The Company does not hold any Ordinary
Shares in treasury. Therefore the total number of voting rights in
the Company is 15,886,660.
The figure of 15,886,660 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated
Adviser & Broker) +44 (0) 20 7496 3000
Richard Lindley
James White
Walbrook Financial PR +44 (0) 20 7933 8780
Paul Cornelius instem@walbrookpr.com
Helen Cresswell
Sam Allen
Paul Whittington
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by customers worldwide and enable
our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit instem.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEMMGZLMLFGNZM
(END) Dow Jones Newswires
September 29, 2017 07:17 ET (11:17 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024